Overview

Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia

Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the effectiveness of two multi-agent chemotherapy regimens using different dosages of cytarabine to eliminate all detectable leukemia.
Phase:
Phase 3
Details
Lead Sponsor:
St. Jude Children's Research Hospital
Collaborator:
National Cancer Institute (NCI)
Treatments:
6-Mercaptopurine
Asparaginase
Cladribine
Cyclophosphamide
Cytarabine
Daunorubicin
Dexamethasone
Etoposide
Gemtuzumab
Mercaptopurine
Methotrexate
Mitoxantrone
Prednisone
Vincristine